🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

1,063 results for “BRIGHT MINDS BIOSCIENCES INC.” Clear

  1. F2F

    BRIGHT MINDS BIOSCIENCES INC.

    Prescription Stimulant Misuse

    phase 1 other active

    1 trial

  2. FAVICOVIR 200 mg Film Tablet

    BRIGHT MINDS BIOSCIENCES INC.

    Bioequivalence

    phase 1 small molecule completed

    1 trial

  3. FAVIR 200 MG FT

    BRIGHT MINDS BIOSCIENCES INC.

    Bioequivalence

    phase 1 small molecule completed

    1 trial

  4. Fenfluramine

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine-Related Disorders

    phase 1 small molecule terminated

    1 trial

  5. Fexofenadine Hydrochloride without sodium lauryl sulfate

    BRIGHT MINDS BIOSCIENCES INC.

    The Impact of Excipients on Drug Absorption

    phase 1 small molecule completed

    1 trial

  6. Fimasartan

    BRIGHT MINDS BIOSCIENCES INC.

    Hypertension

    phase 1 small molecule completed

    1 trial

  7. Four naloxone nasal spray doses (1 every 2.5 min)

    BRIGHT MINDS BIOSCIENCES INC.

    Healthy Subjects

    phase 1 small molecule completed

    1 trial

  8. G207

    BRIGHT MINDS BIOSCIENCES INC.

    Supratentorial Neoplasms, Malignant

    phase 1 mab completed

    1 trial

  9. GBR 12909

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine-Related Disorders

    phase 1 small molecule active

    3 trials

  10. GZ17-6.02

    BRIGHT MINDS BIOSCIENCES INC.

    Advanced Cancer

    phase 1 small molecule active

    1 trial

  11. Gonadorelin

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine-Related Disorders

    phase 1 other completed

    1 trial

  12. HRG80™ Red Ginseng + gamma cyclodextrin

    BRIGHT MINDS BIOSCIENCES INC.

    Drug Absorption

    phase 1 other on hold

    1 trial

  13. HW071021 Tablets

    BRIGHT MINDS BIOSCIENCES INC.

    Advanced Solid Tumors

    phase 1 small molecule active

    1 trial

  14. HW201877 capsules

    BRIGHT MINDS BIOSCIENCES INC.

    Healthy Participants

    phase 1 small molecule active

    1 trial

  15. HWS116 Injection

    BRIGHT MINDS BIOSCIENCES INC.

    Advanced Solid Tumors

    phase 1 small molecule active

    1 trial

  16. Health Promotion and Education

    BRIGHT MINDS BIOSCIENCES INC.

    Cigarette Smoking-Related Carcinoma

    phase 1 other completed

    1 trial

  17. Hydrocodone Bitartrate

    BRIGHT MINDS BIOSCIENCES INC.

    Healthy

    phase 1 small molecule active

    1 trial

  18. Hydrocortisone

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine Use Disorder

    phase 1 small molecule active

    1 trial

  19. INDV-2000

    BRIGHT MINDS BIOSCIENCES INC.

    Healthy Volunteer

    phase 1 small molecule completed

    1 trial

  20. ITI-333

    BRIGHT MINDS BIOSCIENCES INC.

    Healthy Volunteers

    phase 1 small molecule completed

    2 trials

  21. Ibudilast 20mg

    BRIGHT MINDS BIOSCIENCES INC.

    Methamphetamine-dependence

    phase 1 small molecule completed

    1 trial

  22. Inactive Marijuana (0% THC)

    BRIGHT MINDS BIOSCIENCES INC.

    Marijuana Use Disorder

    phase 1 small molecule completed

    1 trial

  23. Incentives for being tobacco free

    BRIGHT MINDS BIOSCIENCES INC.

    Tobacco Prevention and Cessation

    phase 1 other completed

    1 trial

  24. Individualized caffeine cessation instructions

    BRIGHT MINDS BIOSCIENCES INC.

    Self-identified Problematic Caffeine Use

    phase 1 other completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources